ArticleCardiovascular diabetology2026
Cardiac remodeling after bariatric surgery associates with systemic metabolic reprogramming: a longitudinal untargeted metabolomics study.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundObesity is a major contributor to adverse cardiac remodeling, particularly concentric left ventricular remodeling (LVCR), which is associated with diastolic dysfunction and increased cardiovascular risk. Bariatric surgery reverses many obesity-related comorbidities, including structural myocardial alterations. However, the molecular underpinnings of cardiac recovery, particularly metabolomic correlates, remain poorly understood.
objectiveThis study aimed to characterize longitudinal changes in the serum metabolome of patients undergoing bariatric surgery and to investigate the relationship between these metabolic shifts and the regression of concentric cardiac remodeling.
methodsA cohort of 127 adults with severe obesity was evaluated at baseline and 4, 12, and 24 weeks post-surgery. Echocardiographic parameters were assessed to define cardiac remodeling. Untargeted GC-MS-based metabolomic profiling was performed on serum samples. Multivariate models (PLS-DA), LASSO regression, and pathway enrichment analyses were employed to identify discriminant metabolites and predictors of remodeling outcomes.
resultsChanges in cardiac geometry primarily occurred within the first 12 weeks after the intervention and were mainly driven by reductions in relative wall thickness (RWT). Left ventricular mass index (LVMI) showed only modest, non-significant changes at the cohort level, consistent with the predominantly non-hypertrophic baseline profile. Metabolomic profiling showed time-dependent shifts involving amino acid, fatty acid, and ketone metabolism. Patients who experienced early favorable cardiac remodeling after bariatric surgery demonstrated enriched signatures of mitochondrial substrate flexibility, including short-chain fatty acids, branched-chain amino acid metabolites, and dicarboxylic acids. LASSO regression identified specific sets of metabolites associated with reductions in LVMI and RWT.
conclusionEarly geometric cardiac adaptation following bariatric surgery-primarily reflected by reductions in relative wall thickness (RWT), with modest and non-significant changes in LVMI at the cohort level-is associated with coordinated changes in systemic metabolic profiles. These findings suggest potential metabolic correlates of early cardiac adaptation while highlighting substantial interindividual variability. Metabolomic profiling provides insights into individual metabolic trajectories and may inform future strategies for cardiometabolic risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.